1. Risk factors associated with pulmonary hypertension in obesity hypoventilation syndrome
- Author
-
Maria Victoria Mogollon, Juan F. Masa, Shahrokh Javaheri, Babak Mokhlesi, Jose M. Marin, Eusebi Chiner, Sergi Marti, Jaime Corral, Carlos Egea, Iván Benítez, Rocio Gallego, Teresa Gomez-Garcia, Estrella Ordax-Carbajo, Javier Barca, Auxiliadora Romero, Maria A. Sanchez-Quiroga, Soledad López-Martín, Trinidad Díaz-Cambriles, Candela Caballero-Eraso, Francisco Javier Gómez De Terreros, Ferran Barbé, and Mónica González
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Hypertension, Pulmonary ,Body Mass Index ,Hypoxemia ,Hypercapnia ,Risk Factors ,CPAP ,Internal medicine ,Obesity Hypoventilation Syndrome ,Humans ,Medicine ,Obesity ,Obesity hypoventilation syndrome ,business.industry ,Sleep apnea ,Hypoventilation ,medicine.disease ,Scientific Investigations ,Pulmonary hypertension ,Neurology ,Cardiology ,Noninvasive ventilation ,Neurology (clinical) ,medicine.symptom ,business - Abstract
Pulmonary hypertension (PH) is prevalent in obesity hypoventilation syndrome (OHS). However, there is a paucity of data assessing pathogenic factors associated with PH. Our objective is to assess risk factors that may be involved in the pathogenesis of PH in untreated OHS.
- Published
- 2022